And investors looking for corporations that fit the bill should strongly consider Novo Nordisk (NYSE: NVO) and Regeneron Pharmaceuticals (NASDAQ: REGN). Here's why these two drugmakers could be about ...
Pfizer Inc said on Monday it has filed a second lawsuit against its controlling shareholder, Metsera, and Novo Nordisk in a ...
Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback